Myoma - 123 Studies Found Recruiting : A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer : HLRCC Metastatic Papillary RCC : 2010-05-25 : Drug: Bevacizumab Commercially Completed : Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin : Cutaneous Leiomyomas Hereditary Leiomyomatosis and Renal Cell Cancer : 2009-09-03 : Biological: Botulinum toxin type A Recruiting : Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma : Renal Cell Carcinoma Hereditary Leiomyomatosis and Renal Cell Cancer : 2015-07-08 : Drug: Vandetanib Vandetanib is Completed : Surgery for Intravenous Leiomyomatosis : Leiomyomatosis : 2012-10-14 Recruiting : Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer : Renal Tumor Histology Cutaneous Leiomyomatosis Leiomyomatosis : 1999-11-03 Recruiting : A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer : HLRCC Metastatic Papillary RCC : 2010-05-25 : Drug: Bevacizumab Commercially Completed : Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin : Cutaneous Leiomyomas Hereditary Leiomyomatosis and Renal Cell C : 2009-09-03 : Biological: Botulinum toxin type A Completed : Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent : Leiomyoma Leiomyomatosis Uter : 2006-08-03 : Device: Uterine fibroid embolization BeadBlock™ Recruiting : Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma : Renal Cell Carcinoma Hereditary Leiomyomatosis and Renal Cell C : 2015-07-08 : Drug: Vandetanib Vandetanib is Next >>>